Search

everythinglearnresearchcommunity

for

Search:↓

Hepatitis B virus alters steroid hormones in male mice, reducing dihydrotestosterone to inhibit viral replication.

The TrichoConcept™ line is effective for personalized hair loss treatments.

PROTACs have become a breakthrough in medicine by effectively targeting and degrading specific proteins to treat diseases.

Invasomes with 0.5% limonene greatly improve skin delivery of finasteride.

Follicular dystrophy in immunocompromised patients may be linked to medication or viral factors and can improve with treatment changes.

New, cheaper method measures finasteride in tablets accurately and quickly.

Estrogen-progestin contraception lowers ovarian, endometrial, and colon cancer risk but may raise breast and cervical cancer risk, helps with menstrual and acne issues, and new methods are as effective as pills. Metformin helps overweight women with PCOS and insulin resistance, and dopamine agonists treat prolactinomas.

Modified nanofibers improve finasteride skin absorption.

A 5-year-old boy's skin condition improved with systemic valganciclovir after a cardiac transplant and immunosuppressive therapy.

Researchers developed a model to predict how well certain compounds can block an enzyme related to hair loss and prostate issues, suggesting a 50 mg dose of finasteride might be effective based on lab and body data.

Non-daily Dutasteride is more cost-effective and has lower cancer incidence than daily treatment.

Both vaginal testosterone cream and Estring effectively manage vaginal dryness in women with early-stage breast cancer on aromatase inhibitors.

Oral contraceptive use may increase the risk of frontal fibrosing alopecia in women with a specific CYP1B1 gene variant.

Different medications improved various PCOS symptoms and quality of life in Pakistani women, but did not significantly help with excessive hair growth.

Finasteride and dutasteride are equally effective and safe for treating benign prostatic hyperplasia.

Hydroxychloroquine, nitazoxanide, and ivermectin were similarly effective in treating early COVID-19.

Combining oral isotretinoin and rifampicin effectively treats folliculitis decalvans.

Prescriptions for 5-alpha reductase inhibitors dropped significantly after the FDA's safety warning, especially for men with benign prostatic hyperplasia.

A new carrier improves skin delivery of tofacitinib for treating inflammatory skin diseases.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Mefloquine was generally safe at 500 mg weekly, but higher doses caused nausea and diarrhea.

Deucravacitinib did not significantly improve hair regrowth in alopecia areata patients.

New compounds were made and tested, with compound 6 showing potential for treating prostate-related diseases.

Tofacitinib is a potential alternative treatment for alopecia totalis, especially in patients with a shorter duration of the condition and more preserved hair follicles, but the overall response rate is low.